Opioids may help heal chemical-wound skin injuries in humans
Official title: Opioids promote wound healing in vesicant induced skin injury
Funded at Rutgers Biomedical and Health Sciences · NIH-11336772 · Data updated 2026-11-12
A small NIH-funded project will test whether topical opioids can speed up healing after skin damage caused by chemical vesicants like sulfur mustard and nitrogen mustard.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | September 10, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $431,750 |
| NIH project number | 1R21AR087357-01 |
| Project ID | NIH-11336772 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would be individuals with a history of vesicant exposure or related skin injury in a research or clinical setting, under appropriate safety protocols.
✕Less likely to help
People without exposure to vesicants or skin injuries of this type are unlikely to benefit.
What this research studies
This project explores a topical opioid approach to improve skin repair after chemical injury. It builds on prior animal studies showing opioids can influence wound healing, inflammation, and skin cell behavior. Researchers will quantify skin damage and repair after exposure to nitrogen mustard and test the effect of opioid-based treatments in their models. The goal is to identify a potential topical countermeasure that could accelerate healing and reduce injury severity in affected individuals.
Why it matters
Potential benefit: If successful, a topical opioid treatment could speed skin healing after vesicant exposure and reduce complications.
How similar studies have gone: Previous rodent studies showed morphine can enhance wound healing; this project aims to translate those findings to a topical approach.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Joseph, Laurie Beth — Rutgers Biomedical and Health Sciences
- Study coordinator: Joseph, Laurie Beth
Related research
Other NIH-funded projects on the same topics.
-
Immunomodulatory therapy to speed up healing after oral cavity injuries in kids
A new approach using a drug called FTY720 aims to improve healing and reduce pain after oral injuries or palate surgery in children.
-
Aiming to slow dangerous lung inflammation to help fight bacterial infections like tuberculosis
A patient-facing program tests whether stopping a specific inflammatory cell (Spp1+ macrophages) from overreacting can help control tuberculosis and possibly improve outcomes in other inflammatory diseases.
-
Engineered protein materials to study wound healing and blood vessels
A researcher team at the University of New England is studying how the environment around a protein changes its behavior to better understand wound healing and blood vessel formation.
-
Understanding how healing tissue uses tiny messengers and scaffolds to repair wounds
A study to learn how cells talk to each other and how tiny vesicles and the extracellular matrix help skin wounds heal better.
-
Hormone signals and sex differences in how wounds heal
This grant explores how male- and female-specific hormones affect wound healing and scarring, with the goal of improving treatments for people who heal poorly.
-
Therapeutic extracellular vesicles to boost skin wound healing
A research grant is exploring how tiny cell messengers called extracellular vesicles can be engineered to improve skin wound repair in injury models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.